Liquidia Corp (LQDA)
12.85
+0.16
(+1.22%)
USD |
NASDAQ |
May 07, 16:00
12.70
-0.15
(-1.17%)
After-Hours: 20:00
Liquidia Price to Book Value: 20.75 for May 7, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 06, 2024 | 20.50 |
May 03, 2024 | 20.66 |
May 02, 2024 | 20.96 |
May 01, 2024 | 21.27 |
April 30, 2024 | 20.75 |
April 29, 2024 | 20.13 |
April 26, 2024 | 20.24 |
April 25, 2024 | 19.89 |
April 24, 2024 | 20.18 |
April 23, 2024 | 20.82 |
April 22, 2024 | 21.19 |
April 19, 2024 | 21.36 |
April 18, 2024 | 22.20 |
April 17, 2024 | 22.28 |
April 16, 2024 | 21.83 |
April 15, 2024 | 21.99 |
April 12, 2024 | 22.43 |
April 11, 2024 | 24.64 |
April 10, 2024 | 23.84 |
April 09, 2024 | 24.05 |
April 08, 2024 | 24.32 |
April 05, 2024 | 25.26 |
April 04, 2024 | 24.60 |
April 03, 2024 | 24.68 |
April 02, 2024 | 24.72 |
Date | Value |
---|---|
April 01, 2024 | 23.99 |
March 28, 2024 | 23.71 |
March 27, 2024 | 24.23 |
March 26, 2024 | 25.59 |
March 25, 2024 | 25.19 |
March 22, 2024 | 26.90 |
March 21, 2024 | 26.11 |
March 20, 2024 | 25.56 |
March 19, 2024 | 25.76 |
March 18, 2024 | 25.01 |
March 15, 2024 | 25.56 |
March 14, 2024 | 24.63 |
March 13, 2024 | 23.68 |
March 12, 2024 | 22.47 |
March 11, 2024 | 21.88 |
March 08, 2024 | 22.51 |
March 07, 2024 | 21.90 |
March 06, 2024 | 21.85 |
March 05, 2024 | 22.11 |
March 04, 2024 | 21.95 |
March 01, 2024 | 23.28 |
February 29, 2024 | 22.70 |
February 28, 2024 | 23.06 |
February 27, 2024 | 23.55 |
February 26, 2024 | 23.44 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.475
Minimum
Mar 29 2021
33.54
Maximum
Jul 06 2020
6.861
Average
4.533
Median
Oct 17 2019
Price to Book Value Benchmarks
United Therapeutics Corp | 2.214 |
AIM ImmunoTech Inc | 2.225 |
Perspective Therapeutics Inc | 14.33 |
Protalix BioTherapeutics Inc | 2.470 |
Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 47.76 |
PEG Ratio | -0.1400 |
Price | 12.85 |
Earnings Yield | -9.34% |
Market Cap | 981.52M |
PEGY Ratio | -0.1400 |